Type 1 diabetes and hearing loss: Audiometric assessment and measurement of circulating levels of soluble receptor for advanced glycation end products
- 1 September 2020
- journal article
- research article
- Published by Wiley in Diabetes/Metabolism Research and Reviews
- Vol. 36 (6), e3312
- https://doi.org/10.1002/dmrr.3312
Abstract
Background We examined the hearing function in adults with and without type 1 diabetes (T1D) to investigate whether an association exists between hearing loss and duration of diabetes, haemoglobin A1C level, diabetes complications and levels of select serum and urinary biomarkers. Methods We measured pure tone audiometry (PTA) thresholds; serum levels of C-reactive protein (CRP), vascular endothelial growth factor (VEGF), soluble receptors for advanced glycation end-product (sRAGE); and urinary isoprostane in 30 adults with T1D (age 43.8 +/- 11.4 years). We also measured PTA thresholds in 11 adults without diabetes (age 53 +/- 5.5 years). Results 63.3% of adults with T1D had high-frequency hearing loss. Among adults with T1D, those with hearing loss were older (48.2 vs 36.2 years old, P < .01), had a longer duration of diabetes (30.7 vs 21.2 years, P = .02), a greater prevalence of peripheral neuropathy (57.9 vs 9.1%, P = .02) and significantly lower median levels of sRAGE (1054.27 vs 1306.83 pg/mL, P = .03) compared to those with normal hearing. Adults with T1D between the ages of 40 and 60 years old, who had diabetes for >= 35 years, had significantly higher PTA thresholds at both 500and 8000 Hz than age-matched adults without diabetes. Conclusions A significant proportion of adults with T1D have high-frequency hearing loss before age of 60 that is positively associated with age, duration of diabetes and presence of peripheral neuropathy. Our results are in support of previous studies suggesting a potential protective role of sRAGE against AGE toxicity and diabetes complications.Funding Information
- King Saud University
This publication has 38 references indexed in Scilit:
- Hearing Loss Prevalence and Risk Factors Among Older Adults in the United StatesThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2011
- Expression of advanced glycation end‐product receptors in the cochleaThe Laryngoscope, 2010
- Potential Mediators of Diabetes-Related Hearing Impairment in the U.S. PopulationDiabetes Care, 2010
- Correlation of hearing function findings in patients suffering from diabetes mellitus type 1 in regard to age and genderMedicinski Pregled, 2009
- Severity of diabetic microvascular complications is associated with a low soluble RAGE levelDiabetes & Metabolism, 2008
- Identification, classification, and expression ofRAGEgene splice variantsThe FASEB Journal, 2007
- Low Circulating Endogenous Secretory Receptor for AGEs Predicts Cardiovascular Mortality in Patients With End-Stage Renal DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Race and Sex Differences in Age‐Related Hearing Loss: The Health, Aging and Body Composition StudyJournal of the American Geriatrics Society, 2005
- Insulin‐dependent diabetic microangiopathy in the inner earThe Laryngoscope, 1995
- Is NIDDM a risk factor for noise-induced hearing loss in an occupationally noise exposed cohort?Science of The Total Environment, 1992